Paper Title:
Preparation of Targeting Vehicles for The Delivery of N-Bisphosphonates
  Abstract

Bisphosphonates (BP) are drugs currently administered orally to treat diseases characterised by an excessive bone resorption. Alternative and more efficient delivery routes and more potent compounds are being investigated. Three implantable delivery systems, which allow the controlled release of therapeutic agents from the device core, are examined in this paper. (4- (aminomethyl) benzene) bisphosphonic acid (ABBP) was incorporated on Ca8.8Na0.8(PO4)4.8(CO3)1.2(OH)0.4F1.6 particles by refluxing the powder in a 60 mmol suspension in acetone at 60°C for 5 hours. 4-aminophenyl acetic bisphosphonate monosodium salt (APBP) and 1- H-indole-3-acetic bisphosphonate monosodium (IBP) were loaded on Ca10(PO4)6(OH)1F1 ceramic bodies by stirring the ceramic bodies in 0.04M BP solutions. Injectable acrylic cements based on self-curing formulations of methyl methacrylate (MMA) and vitamin E were loaded with APBP and IBP. The incorporation of ABBP was confirmed by MAS-NMR spectroscopy. Modified powder shows two different phosphorous environments, the first one at 2.91 ppm can be assigned to the apatite base and the second one at 18.0 ppm has to be attributed to the phosphonic group of the ABBP. The IBP addition on ceramic surfaces did not decrease the number of osteoclast colonies and appeared to improve the performance of the HA as a surface for osteoblast culture. A therapeutic dosage of APBP and IBP can be achieved from acrylic cements that showed lack of toxicity and an increased cellular activity and proliferation.

  Info
Periodical
Key Engineering Materials (Volumes 330-332)
Main Theme
Edited by
Xingdong Zhang, Xudong Li, Hongsong Fan, Xuanyong Liu
Pages
1041-1044
DOI
10.4028/www.scientific.net/KEM.330-332.1041
Citation
L. M. Rodríguez-Lorenzo, M. Fernandez, J. Parra, B. Vázquez, A. López-Bravo, J. San Román, K. A. Gross, G. I. Anderson, "Preparation of Targeting Vehicles for The Delivery of N-Bisphosphonates", Key Engineering Materials, Vols. 330-332, pp. 1041-1044, 2007
Online since
February 2007
Export
Price
$32.00
Share

In order to see related information, you need to Login.

In order to see related information, you need to Login.

Authors: Luis M. Rodríguez-Lorenzo, Blanca Vázquez, Julio San Román, Kārlis A. Gross
Abstract:Bisphosphonates (BPs) may play an important role in minimizing osteolysis. In this work two new bisphosphonates pertaining to second and...
899
Authors: M.B. Queiroz, Simone C.Gallani Rodrigues, Herve M. Laborde, Meiry Glaúcia Freire Rodrigues
Abstract:Brasgel clay has been modified via cation exchange reaction using quaternary ammonium chlorides (stearyl dimethylammonium chloride,...
1031
Authors: Razvan Adam, Carmen Orban, Nicolae Gheorghiu, Horia Orban, Iulian Vasile Antoniac
Chapter 3: Biomaterials and Technologies in Clinical Practice
Abstract:Bisphosphonates currently represent the main therapy in the fight against osteoporosis. This is a serious condition, with an increasing...
296
Authors: Alexandra M. Brown, Yoliem S. Miranda-Alarćon, Grant A. Knoll, Steven M. Romanelli, Ipsita A. Banerjee
Abstract:Although effective, chemotherapeutic drugs often cause undesired side-effects. Thus, encapsulating chemotherapeutic drugs into nanoscale drug...
33